M2 Financial, alongside Capital-FORCE ETF Trust, has completed the transition of two Investor's Business Daily (IBD)-licensed strategies—CapForce IBD 50 ETF (NYSE:FFTY) (earlier, Innovator IBD 50 ETF) and CapForce IBD Breakout Opportunities ETF (NYSE:BOUT) (earlier, Innovator IBD Breakout Opportunities ETF)—onto the Capital-FORCE platform, marking a key step in the firm's push to build a focused suite of rules-based ETFs.
The FFTY and BOUT are based on IBD's long-standing methodology for identifying market leadership within a modern ETF wrapper.
CEO Mark MacArthur said the transition aligns research-driven stock selection with the growing investor preference for transparent, rules-based vehicles.
The firm expects to leverage enhanced distribution, marketing, and operational efficiencies to expand the reach of these strategies, while using them as a foundation to roll out additional ETFs built on similar principles.
Key Features Of The Transition And Strategy
- Retains ticker symbols FFTY and BOUT, ensuring continuity for existing investors
- Rebrands funds under the CapForce identity, with updated names
- FFTY and BOUT, for now, retain the expense ratios of 0.8% each
- Leverages IBD's methodology focused on identifying market leaders and breakout stocks
- Emphasizes rules-based, dynamic portfolio construction across market cycles
- Aims to expand adoption through improved distribution and operational scale
- Serves as a foundation for a broader lineup of factor-driven, transparent ETF strategies
The transition follows shareholder approval secured earlier this month, when investors in the funds voted in favor of reorganizing the funds into newly created CapForce equivalents.
The April 10 meeting cleared the way for both ETFs to move under the Capital-FORCE ETF Trust, effectively converting the Innovator-branded products into CapForce IBD funds, and paving the path for the platform shift announced this week.
Image: Shutterstock
Login to comment